Get the Stockscreener App
38.07
2.82%
-1.07
Vericel Corp stock is traded at $38.07, with a volume of 103.24K.
It is down -2.82% in the last 24 hours and up +1.75% over the past month.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$39.14
Open:
$39.14
24h Volume:
103.24K
Relative Volume:
0.17
Market Cap:
$1.92B
Revenue:
$249.12M
Net Income/Loss:
$7.11M
P/E Ratio:
305.54
EPS:
0.1246
Net Cash Flow:
$-8.30M
1W Performance:
+1.70%
1M Performance:
+1.75%
6M Performance:
-5.74%
1Y Performance:
-33.76%
1-Day Range:
$37.95
$39.48
1-Week Range:
$35.84
$39.48
52-Week Range:
$29.24
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
37.99 | 1.98B | 249.12M | 7.11M | -8.30M | 0.1246 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
Cartilage Repair-Cartilage Regeneration Market Covering - openPR.com
Is Vericel Corporation stock heavily shorted2025 Volatility Report & AI Enhanced Trading Alerts - bollywoodhelpline.com
Will Vericel Corporation (ATQP) stock boost dividends furtherJuly 2025 Breakouts & Fast Moving Stock Trade Plans - bollywoodhelpline.com
Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Vericel (NASDAQ:VCEL) Stock Rating Lowered by Wall Street Zen - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Debt-Free Balance Sheet, MACI Momentum, And Burn Care Portfolio Put Vericel On Investors' Radar - RTTNews
Why Is Vericel Stock Gaining Tuesday? - Benzinga
Vericel reports preliminary 2025 revenue of $276 million By Investing.com - Investing.com Canada
Vericel reports preliminary 2025 revenue of $276 million - Investing.com
Vericel Corporation Anticipates $276 Million Total Revenue and 23% Growth in Fourth Quarter Results - Quiver Quantitative
Vericel (NASDAQ: VCEL) shares preliminary 2025 results, updates outlook - Stock Titan
Vericel Announces Preliminary 2025 Financial Results and Business Updates - Yahoo Finance
Vericel Corporation (VCEL) Stock Analysis: Unveiling A 50% Upside In The Biotech Sector - DirectorsTalk Interviews
Summit Creek Advisors LLC Acquires 138,124 Shares of Vericel Corporation $VCEL - MarketBeat
Vericel Corporation $VCEL Shares Sold by Conestoga Capital Advisors LLC - Defense World
How institutional buying supports Vericel Corporation stockJuly 2025 Review & Risk Managed Investment Entry Signals - Улправда
Bond Watch: Why analysts upgrade Vericel Corporation stockFed Meeting & Free Long-Term Investment Growth Plans - Улправда
Why analysts upgrade Vericel Corporation stockCPI Data & Short-Term Trading Opportunity Alerts - Улправда
Shares soar in Vericel after trial shows ixmyelocel-T reduces cardiac events - The Pharma Letter
Vericel Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Quiver Quantitative
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 - Yahoo Finance
VCEL Crosses Above Key Moving Average Level - Nasdaq
Vericel: Growth Plans May Have Run Out Of Gas (Rating Downgrade) - Seeking Alpha
Vericel (NASDAQ:VCEL) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Vericel (VCEL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Vericel Corporation (NASDAQ:VCEL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Vericel Corporation (ATQP) stock sustain uptrend momentumStock Watchlist Updates & Free Trading Signals to Sharpen Your Edge - bollywoodhelpline.com
How Investors Are Reacting To Vericel (VCEL) Reaffirmed Guidance And MACI-Focused Growth Narrative - simplywall.st
Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50 - Insider Monkey
Congress Asset Management Co. Lowers Stake in Vericel Corporation $VCEL - MarketBeat
Vericel price target lowered to $45 from $50 at Truist - MSN
VCEL (Vericel) EV-to-OCF : 30.39 (As of Dec. 19, 2025) - GuruFocus
How Vericel Corporation stock reacts to inflationary pressures2025 Valuation Update & Weekly Market Pulse Updates - DonanımHaber
Why Vericel Corporation stock could see breakout soonMarket Volume Report & Long-Term Safe Investment Plans - DonanımHaber
Vericel (VCEL) Sees Target Price Lowered by Truist Securities | - GuruFocus
VCEL FinancialsIncome Statement - Quiver Quantitative
Here's Why We Think Vericel (NASDAQ:VCEL) Might Deserve Your Attention Today - Yahoo Finance
Institutional Investors Accumulate Vericel Shares Amid Positive Earnings Shift - AD HOC NEWS
Vericel Corp (VCEL) CHRO receives 2,625 shares from RSU vesting on 07/22/2025 - Stock Titan
Osterweis Capital Management Inc. Takes $9.71 Million Position in Vericel Corporation $VCEL - MarketBeat
Next Century Growth Investors LLC Has $28.45 Million Stock Position in Vericel Corporation $VCEL - MarketBeat
How Vericel’s Q3 Beat and MACI Arthro Momentum Could Shape Vericel (VCEL) Investors’ Outlook - simplywall.st
Russell Investments Group Ltd. Purchases 32,976 Shares of Vericel Corporation $VCEL - MarketBeat
Is Vericel’s Recent Pullback a Chance or a Warning for Investors in 2025? - simplywall.st
Vericel (VCEL) director Wotton sells $189500 in stock - Investing.com India
Director’s Big Move: Vericel Stock Sale Shakes Up the Market! - TipRanks
Insider Sell: Paul Wotton Sells 5,000 Shares of Vericel Corp (VC - GuruFocus
Vericel’s chief medical officer sells $64,659 in VCEL stock By Investing.com - Investing.com South Africa
Vericel (VCEL) director Wotton sells $189500 in stock By Investing.com - Investing.com South Africa
Vericel’s chief medical officer sells $64,659 in VCEL stock - Investing.com India
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.38%
1.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):